BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 3, 2016
View Archived Issues
FDA approves blood-based companion diagnostic for Tagrisso
Read More
Cempra announces encouraging interim data from phase II trial of solithromycin in NASH
Read More
Micatrio approved in Japan for hypertension
Read More
Phase II efficacy results for ABT-436 in alcohol-dependent subjects
Read More
Safety and efficacy of durvalumab in patients with advanced urothelial bladder cancer
Read More
Combination of routine biochemical markers improves the management of patients with MDD
Read More
Bayer Pharma patents prostanoid FP antagonists
Read More
Bayer Pharma discloses coagulation factor XIa and kallikrein inhibitors
Read More
Roche describes mGlu4 receptor positive allosteric modulators
Read More
Cellectar Biosciences reports positive data on phase I trial of CLR-131
Read More
Hetero Research Foundation develops antiviral agents
Read More
Genentech and Roche present JAK1 inhibitors
Read More
Catabasis and Sarepta enter joint DMD research collaboration
Read More
EMA accepts and validates masitinib MAA for ALS
Read More
Boehringer Ingelheim and Sarah Cannon Institute enter collaboration for cancer drug development
Read More
Reducing off-target NELL-1 effects
Read More
Celgene exercises option to obtain ex-U.S. rights to Abide's ABX-1431
Read More
Bill & Melinda Gates Foundation gives grant to Sirenas
Read More
Cognition Therapeutics receives grant from Michael J. Fox Foundation for research in Parkinson's
Read More
Novel T-type calcium channel blockers show analgesic effects in vivo
Read More
Allergan licenses MEDI-2070 rights from MedImmune
Read More
FDA completes IND review for phase II study of nilotinib in patients Alzheimer's disease
Read More
Promising data from first phase III trial of Cimzia in moderate to severe chronic plaque psoriasis
Read More
Regeneron reports topline data from phase II trial of aflibercept/rinucumab in wet AMD
Read More
Glecaprevir/pibrentasvir investigational HCV regimen receives FDA breakthrough therapy designation
Read More
Truberzi approved in E.U. for IBS-D
Read More
Proveca's Sialanar approved in Europe for sialorrhea
Read More